JCR Pharmaceuticals Co Ltd
TSE:4552
Intrinsic Value
JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. [ Read More ]
The intrinsic value of one JCR Pharmaceuticals Co Ltd stock under the Base Case scenario is 1 609.08 JPY. Compared to the current market price of 859 JPY, JCR Pharmaceuticals Co Ltd is Undervalued by 47%.
Valuation Backtest
JCR Pharmaceuticals Co Ltd
Run backtest to discover the historical profit from buying and selling JCR Pharmaceuticals Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
JCR Pharmaceuticals Co Ltd
Current Assets | 57.5B |
Cash & Short-Term Investments | 18.3B |
Receivables | 16.3B |
Other Current Assets | 22.9B |
Non-Current Assets | 45.3B |
Long-Term Investments | 9.3B |
PP&E | 30.7B |
Intangibles | 3.6B |
Other Non-Current Assets | 1.8B |
Current Liabilities | 31.9B |
Accounts Payable | 1.6B |
Accrued Liabilities | 607m |
Other Current Liabilities | 29.7B |
Non-Current Liabilities | 15.2B |
Long-Term Debt | 13.6B |
Other Non-Current Liabilities | 1.6B |
Earnings Waterfall
JCR Pharmaceuticals Co Ltd
Revenue
|
41.4B
JPY
|
Cost of Revenue
|
-10.4B
JPY
|
Gross Profit
|
31B
JPY
|
Operating Expenses
|
-23.1B
JPY
|
Operating Income
|
7.8B
JPY
|
Other Expenses
|
-2.5B
JPY
|
Net Income
|
5.4B
JPY
|
Free Cash Flow Analysis
JCR Pharmaceuticals Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
JCR Pharmaceuticals Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
JCR Pharmaceuticals Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
JCR Pharmaceuticals Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Score
JCR Pharmaceuticals Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
JCR Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for JCR Pharmaceuticals Co Ltd is 1 823.25 JPY with a low forecast of 1 212 JPY and a high forecast of 2 835 JPY.
Shareholder Return
Price
JCR Pharmaceuticals Co Ltd
Average Annual Return | 2.3% |
Standard Deviation of Annual Returns | 26.57% |
Max Drawdown | -77% |
Market Capitalization | 107.2B JPY |
Shares Outstanding | 124 776 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ashiya-Shi, Hyogo-Ken and currently employs 732 full-time employees. The firm operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
Contact
IPO
Employees
Officers
The intrinsic value of one JCR Pharmaceuticals Co Ltd stock under the Base Case scenario is 1 609.08 JPY.
Compared to the current market price of 859 JPY, JCR Pharmaceuticals Co Ltd is Undervalued by 47%.